NO981361L - Syntetiske flervalente sLEX inneholdende polyaktosaminer og anvendelse derav - Google Patents

Syntetiske flervalente sLEX inneholdende polyaktosaminer og anvendelse derav

Info

Publication number
NO981361L
NO981361L NO981361A NO981361A NO981361L NO 981361 L NO981361 L NO 981361L NO 981361 A NO981361 A NO 981361A NO 981361 A NO981361 A NO 981361A NO 981361 L NO981361 L NO 981361L
Authority
NO
Norway
Prior art keywords
polyactosamines
relates
constructs
synthetic polyvalent
slex
Prior art date
Application number
NO981361A
Other languages
English (en)
Norwegian (no)
Other versions
NO981361D0 (no
Inventor
Ossi Renkonen
Risto Renkonen
Original Assignee
Glycim Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycim Oy filed Critical Glycim Oy
Publication of NO981361D0 publication Critical patent/NO981361D0/no
Publication of NO981361L publication Critical patent/NO981361L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO981361A 1995-09-29 1998-03-25 Syntetiske flervalente sLEX inneholdende polyaktosaminer og anvendelse derav NO981361L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US462395P 1995-09-29 1995-09-29
US786795P 1995-12-01 1995-12-01
PCT/FI1996/000513 WO1997012892A1 (fr) 1995-09-29 1996-09-27 sLEX SYNTHETIQUE POLYVALENT CONTENANT DES POLYLACTOSAMINES ET PROCEDES D'UTILISATION

Publications (2)

Publication Number Publication Date
NO981361D0 NO981361D0 (no) 1998-03-25
NO981361L true NO981361L (no) 1998-05-26

Family

ID=26673254

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981361A NO981361L (no) 1995-09-29 1998-03-25 Syntetiske flervalente sLEX inneholdende polyaktosaminer og anvendelse derav

Country Status (11)

Country Link
US (1) US5965544A (fr)
EP (1) EP0874861A1 (fr)
JP (1) JP2000507993A (fr)
AU (1) AU713078B2 (fr)
CA (1) CA2231073A1 (fr)
CZ (1) CZ89098A3 (fr)
HU (1) HUP9900058A2 (fr)
NO (1) NO981361L (fr)
PL (1) PL325873A1 (fr)
SK (1) SK39498A3 (fr)
WO (1) WO1997012892A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
US6841543B1 (en) * 1996-01-31 2005-01-11 President And Fellows Of Harvard College Methods of inhibiting production of T helper type 2 cytokines in human immune cells
EP0926154B1 (fr) * 1996-07-23 2010-01-27 Seikagaku Corporation Nouveaux oligosaccharides a base de lactosamine et procede de preparation
CA2302470A1 (fr) * 1997-09-05 1999-03-18 Ossi Renkonen Polylactosamines synthetiques contenant un slex divalent et ses methodes d'utilisation
US7018637B2 (en) * 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
WO2001085177A1 (fr) * 2000-05-11 2001-11-15 The Burnham Institute Antigene meca-79 et methodes y relatifs
AU7684201A (en) * 2000-06-28 2002-01-08 Glycofi Inc Methods for producing modified glycoproteins
EP1311550A2 (fr) * 2000-08-22 2003-05-21 National Research Council Of Canada Synthese de glucides complexes
US20050026866A1 (en) * 2002-08-02 2005-02-03 Pawelek John M. Agents and methods for treatment of disease by oligosaccharide targeting agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
WO1991019501A1 (fr) * 1990-06-15 1991-12-26 Cytel Corporation Mediateurs d'adherence intercellulaire
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5352670A (en) * 1991-06-10 1994-10-04 Alberta Research Council Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
CA2110797C (fr) * 1991-06-10 2001-02-20 Andre P. Venot Composes lewis x sialyliques modifies
CA2129140A1 (fr) * 1992-01-31 1993-08-05 Akira Hasegawa Derive d'une chaine de sucre de type lewis
JPH0686684A (ja) * 1992-05-26 1994-03-29 Monsanto Co シアロ抱合体の合成
US5591835A (en) * 1992-06-29 1997-01-07 Glycomed Incorporated Substituted lactose derivatives
US5426178A (en) * 1993-03-31 1995-06-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis of anti-inflammatory compounds, and novel trisaccharides useful in the synthesis of anti-inflammatory compounds
ATE204478T1 (de) * 1993-05-03 2001-09-15 Genentech Inc Inhibierung von leukozytenadhäsion
US5374541A (en) * 1993-05-04 1994-12-20 The Scripps Research Institute Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
US5409817A (en) * 1993-05-04 1995-04-25 Cytel, Inc. Use of trans-sialidase and sialyltransferase for synthesis of sialylα2→3βgalactosides
WO1994026760A1 (fr) * 1993-05-14 1994-11-24 Cytel Corporation ANALOGUES DE SIALYLE Lex UTILES EN TANT QU'INHIBITEURS DE L'ADHESION CELLULAIRE
WO1995001361A1 (fr) * 1993-07-02 1995-01-12 Nippon Shinyaku Co., Ltd. Derive de galactosylmoranoline
US5559103A (en) * 1993-07-21 1996-09-24 Cytel Corporation Bivalent sialyl X saccharides
WO1995006057A1 (fr) * 1993-08-23 1995-03-02 Nippon Shinyaku Co., Ltd. Derive de galactosylmoraniline
EP0671409A3 (fr) * 1994-03-11 1996-06-12 Hoechst Ag Dérivés de l'acide malonique ayant des propriétés anti-adhésives.
HUT77345A (hu) * 1994-04-29 1998-03-30 Texas Biotechnology Corporation E-szelektin, P-szelektin vagy L-szelektin szialil-Lewis x-hez vagy szialil-Lewis a-hoz kapcsolódását gátló mannopiranoziloxi-bifenil származékok és ezeket tartalmazó gyógyszerkészítmények

Also Published As

Publication number Publication date
AU713078B2 (en) 1999-11-25
PL325873A1 (en) 1998-08-17
CA2231073A1 (fr) 1997-04-10
HUP9900058A2 (hu) 1999-04-28
AU7087296A (en) 1997-04-28
WO1997012892A1 (fr) 1997-04-10
JP2000507993A (ja) 2000-06-27
CZ89098A3 (cs) 1998-09-16
SK39498A3 (en) 1999-01-11
US5965544A (en) 1999-10-12
EP0874861A1 (fr) 1998-11-04
NO981361D0 (no) 1998-03-25

Similar Documents

Publication Publication Date Title
Michon et al. Structure of the L5 lipopolysaccharide core oligosaccharides of Neisseria meningitidis.
NO981361L (no) Syntetiske flervalente sLEX inneholdende polyaktosaminer og anvendelse derav
DE69702911T2 (de) Oxydierte oligosaccharide
MEP48408A (en) Anti-tnf antibodies, compositions, methods and uses
DK0699104T3 (da) Fremgangsmåde til underkritisk tørring af aerogeler
KR850008282A (ko) 그람음성균상의 혈청형 리포다당류 결정인자에 대한 인체 단크론(monoclonal)항체와 그 제조방법
EP2090657A3 (fr) Anticorps anti-IL-12, compositions, procédés et utilisations
DK1261368T3 (da) Tværbunden, ikke-fungal lipaseholdig sammensætning og fremgangsmåder til anvendelse deraf
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
ATE181921T1 (de) Chromatographische isolierung von nucleinsäuren
KR950031099A (ko) 유산균 함유 사하약 조성물
KR870002826A (ko) 퍼어머넌트 웨이브 용제
DE59603678D1 (de) Kohlenhydratmodifizierte cytostatika
FI931714A (fi) Fukthaerdbar en-komponent polysiloxanfoerening
NO20001091L (no) Syntetisk divalent sLex inneholdende polylaktosaminer og fremgangsmåter for anvendelse
PT83255B (pt) Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirus
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
DE69507947T2 (de) Fliessfähigkeitregelung von zementzusammensetzungen
BR0116790A (pt) Sistema de catalisador e seu uso em um processo de polimerização
ATE148723T1 (de) Hydrophile gruppen aufweisende organopolysiloxane
FI962323A0 (fi) N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit
FI963289A (fi) Öljykoostumukset
WO1999047558A3 (fr) Nouvelles formes de protèines de co-stimulation des lymphocytes t, molècules d'acide nuclèique et leur utilisation
WO1994025598A3 (fr) PROCEDES ET COMPOSITIONS DESTINES A DES VACCINS A BASE DE $i(SALMONELLA)
NO20010140L (no) Kjemotakse-inhiberende protein av Staphylococcus (CHIPS) og dets anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application